Cytokine alterations in lichen sclerosus: An immunohistochemical study

British Journal of Dermatology

Volumn 155, Issue 5, 2006, Pages 931-940

  Farrell, A M ^a   Dean, D ^b   Millard, P R ^b   Charnock, F M ^b   Wojnarowska, F ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Intercellular adhesion molecule 1; Interferon ; Interleukin 1 ; Interleukin 2 receptor; Lichen sclerosus; Tumour necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACCURACY; ADULT; AGED; ARTICLE; CHRONIC WOUND; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; EPIDERMIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KERATINOCYTE; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VULVA;

AGED; ANTIGENS, CD; CYTOKINES; EPIDERMIS; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-1ALPHA; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; RECEPTORS, INTERFERON; TUMOR NECROSIS FACTOR-ALPHA; VULVA; VULVAR LICHEN SCLEROSUS;

EID: 33749850015     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07414.x     Document Type: Article

References (39)

1. Farrell AM, Marren P, Dean D et al. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin. Br J Dermatol 1999; 140:1087-92.
2. Griffiths CEM, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma-interferon and tumor necrosis factor. J Am Acad Dematol 1989; 20:617-29.
3. Asaku R, From L, Kahn HJ. Lymphocyte and macrophage subsets in active and inactive lesions of lichen planus. Am J Dermatopathol 1993; 15:217-23.
4. Karagouni EE, Dotsika EN, Sklavounou A. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. J Oral Pathol Med 1994; 23:28-35.
5. Kapp A, Piskorski A, Schöpf E. Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis. Br J Dermatol 1988; 119:707-10.
6. Terajima S, Higaki M, Igarashi Y et al. An important role of tumor necrosis factor-α in the induction of adhesion molecules in psoriasis. Arch Dermatol Res 1998; 290:246-52.
7. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18:263-6.
8. Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity, a study of 350 women. Br J Dermatol 1988; 118:41-6.
9. Carli P, Moretti S, Spallanzani A et al. Fibrogenic cytokines in vulvar lichen sclerosus: an immunohistochemical study. J Reprod Med 1997; 42:161-5.
10. Serpier H, Gillery P, Salmon-Ehr V. Antagonistic effects of interferon-γ and interleukin-4 on fibroblast cultures. J Invest Dermatol 1997; 109:159-62.
11. Czaja MJ, Weiner R, Eghbali M et al. Differential effects of interferon on collagen and fibronectin gene expression. J Biol Chem 1987; 262:13348-51.
12. Adelmann-Grill BC, Hein R, Wach F, Krieg T. Inhibition of fibroblast chemotaxis by recombinant human interferon γ and interferon α. J Cell Physiol 1987; 130:270-5.
13. Telek G, Sinclair R, Ryan T et al. Do lymphocyte products contribute to wound failure? Wound Repair Regen 1994; 2:226 (abstract).
14. Grassegger A, Schuler G, Hessenberger G et al. Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial. Br J Dermatol 1998; 139:639-48.
15. Panizzon R, Vuorio T, Bruckner-Tuderman L. Collagen biosynthesis and type I and type III procollagen mRNA in lichen sclerosus et atrophicus. Arch Dermatol Res 1990; 282:480-3.
16. Oikarinen A, Sandberg M, Hurskainen T et al. Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridization techniques. Acta Derm Venereol (Stockh) 1991; 162 (Suppl.):3-12.
17. Griffiths MR, Priestley GC. A comparison of morphoea and lichen sclerosus et atrophicus in vitro: the effects of para-aminobenzoate on skin fibroblasts. Acta Derm Venereol (Stockh) 1992; 72:15-18.
18. Auböck J, Romani N, Grubauer G, Fritsch P. HLA-DR expression on keratinocytes is a common feature of diseased skin. Br J Dermatol 1986; 114:465-72.
19. Basham T, Nickoloff B, Merigan T. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol 1984; 83:88-90.
20. Scheynius A, Fransson J, Johansson C et al. Expression of interferon-gamma receptors in normal and psoriatic skin. J Invest Dermatol 1992; 98:255-8.
21. Vassalli P. The pathophysiology of tumour necrosis factors. Annu Rev Immunol 1992; 10:411-52.
22. Farrell AM, Millard PR, Schomberg KH, Wojnarowska F. An infective aetiology for lichen sclerosus re-addressed. Clin Exp Dermatol 1999; 24:479-83.
23. Barker JNWN, Sarma V, Mitra RS et al. Marked synergism between tumour necrosis factor-α and interferon-γ in the regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 1990; 85:605-8.
24. Scharffetter K, Heckmann M, Hatamochi A et al. Synergistic effect of tumour necrosis factor-α and interferon-γ on collagen synthesis of human skin fibroblasts in vitro. Exp Cell Res 1989; 181:409-19.
25. Scheurich P, Thoma B, Ücer U, Pfizenmaier K. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-α: induction of TNF receptors on human T cells and TNF-α-mediated enhancement of T cell responses. J Immunol 1987; 138:1786-90.
26. Rambaldi A, Young DC, Herrmann F et al. Interferon-γ induces expression of the interleukin 2 receptor gene in human monocytes. Eur J Immunol 1987; 17:153-6.
27. Dinarello CA. Interleukin 1 and interleukin 1 receptor antagonism. Blood 1991; 77:1627-52.
28. Kristensen M, Deleuran B, Eedy DJ et al. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1α in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 1992; 127:305-11.
29. Mizutami H, Black M, Kupper TS. Human keratinocytes produce but do not process pro-interleukin 1 beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 1991; 87:1066-71.
30. Postlethwaite AE, Raghow R, Stricklin GP et al. Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1α and β. J Cell Biol 1988; 106:311-18.
31. White B. Immune abnormalities in systemic sclerosis. Clin Dermatol 1994; 12:349-59.
32. Clay FE, Cork MJ, Tarlow JK et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994; 94:407-10.
33. Ashida Y, Ogo M, Denda M. Epidermal interleukin-1α is amplified at low humidity: implications for the pathogenesis of inflammatory dermatoses. Br J Dermatol 2001; 144:238-43.
34. Figdor CG, van Kooyk Y, Keizer GD. On the mode of action of LFA-1. Immunol Today 1990; 11:277-80.
35. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon-γ and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med 1988; 167:1323-40.
36. Bennion SD, Middleton MH, David-Bajar KM et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol 1995; 105:S71-9.
37. Dustin ML, Rothlein R, Bhan AK et al. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137:245-54.
38. Munro JM, Pober JS, Cotran RS. Cytokine-induced endothelial activation and mononuclear cell infiltration in baboon skin in vivo. FASEB J 1988; 2:A1821 (Abstract).
39. Connelly MG, Winkelmann RK. Coexistence of lichen sclerosus, morphea and lichen planus. J Am Acad Dermatol 1985; 12:844-51.